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Introduction/Aim: Current guidelines consider a positive
prostate biopsy (Bx) result as an important requirement in
men seeking to undergo salvage radical prostatectomy (sRP)
after biochemical recurrence (BCR). However, results of
confirmatory pre-sRP biopsy (cBx) have never been
reported in large contemporary cohorts. Our aim was to
evaluate the detection rate of pre-sRP prostate Bx; to
establish the Gleason score (GS) concordance (Conc) of
cBx and first diagnostic biopsy (fBx) with the final sRP
specimen GS, respectively; to analyse the GS Conc between
the fBx and cBx GS. Materials and Methods: We
retrospectively collected data of 209 men who underwent sRP
after BCR at 10 European high-volume centres between 1991
and 2015. Clinical and pathological features, including age,
prostate-specific antigen (PSA), TNM, imaging and previous
treatments were recorded. FBx, cBx and sRP GS sums were
categorised in ≤6, 7, 8, 9 and 10. Men without appropriate
information or undergoing sRP without an available cBx
result were excluded. Cohen’s Kappa coefficient was used for
Conc to consider inter-rater agreement. Detection rate and
Conc, upgrading (UpGr) and downgrading (DownGr) are
reported as number of events and percentages. Results: One
hundred and sixty six men were included. Mean age, initial
and pre-sRP PSA were 64.8±6.1 years, 19.6 and 8.7 ng/ml,
respectively. Pathological stage of the sRP specimen was pT2
in 43.7% and pT3 in 54.4%. Two cases were pT0 and no pT4
were present. All had negative imaging for extra-nodal
metastasis. Sixty percent of the patients had hormone therapy
before sRP. CBx Detection rate was 89.8% (n=149) with the
remaining 10.24% (n=17) having no prostate cancer diagnosis
due to radiation injury or absence of tumour being detected.
Conc, UpGr and DownGr between cBx and sRP specimens
were 61.1% (n=88, k=0.208), 28.5% (n=41) and 10.4%
(n=15). Five sRP specimens were not evaluable due to
radiation injury or had no tumour. Conc, UpGr and DownGr
between fBx and cBx were 48.9 (n=45, k=0.284), 43.8 (n=40)
and 7.61 (n=7) (fBx missing n=57). Conc, UpGr and DownGr
between fBx and sRP specimens were 36.7% (n=32,
k=0.105), 55.1% (n=48) and 8.0% (n=7), respectively.
Conclusion: Pre-sRP confirmatory biopsy has an appropriate
ability of confirming the presence of tumour. However, it
underestimates GS in a significant proportion of men,
having a higher GS at the final histology of the sRP
specimen. The original diagnostic biopsy is not a reliable
source of GS information when planning second-line
treatment after BCR as it is upgraded in more than half of
the cases.
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Introduction/Aim: Indications, techniques and outcomes of
lymph node dissection (LND) for upper tract urothelial
carcinoma (UTUC) are still debated. Although potential
benefits of LND have been described in literature,
hesitancy and lack of standardization still exists even
among academic institutions. The aim of the study was to
provide a comprehensive overview on anatomical
landmarks of LND for UTUC and propose evidence-based
templates according to the location of the primary tumor.
Materials and Methods: A systematic review of the
English-language literature up to June 1, 2015, was
performed using the Medline, Scopus and Web of
Sciences databases according to the PRISMA criteria.
Cohort studies providing detailed data on the surgical
template of LND were included and analyzed. Results: A
total of 702 articles were identified. After study selection,
16 studies recruiting 1,705 patients were selected for
review and critically analyzed. Among these, most were
single-centre, retrospective cohort studies, of which 2
mapping studies. Sample size, tumor location and stage
were highly variable across the published series. An open
surgical approach was used in most cases. No
standardized selection criteria for LND were followed,
being LND performed at surgeon’s discretion and/or based
on pre/intraoperative suspicion of LN metastases. In most
studies, the extent of LND was not standardized. An
overview of the LND templates according to the current
literature are shown in Figure 1, while the proposed
standardized templates based on the available mapping
studies in Figure 2 (A-C). Discussion and Conclusion:
Indications and templates of LND for UTUC are still
controversial. We have proposed standardized evidence-
based templates to improve the quality of future clinical
series. Further research is needed to validate these
templates to understand the exact patterns of lymphatic
drainage from UTUCs. 
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Figure 1. Schematic view of surgical anatomy (left picture) and critical sites of lymph node dissection (right picture) for upper tract urothelial
carcinoma. A, aorta; IVC, inferior vena cava; GV, gonadal vein; GA, gonadal artery; AB, aortic bifurcation; VCB, vena cava bifurcation; CIA,
common iliac artery; EIA, external iliac artery; IIA, internal iliac artery; CIAB, common iliac artery bifurcation; RH, renal hilum; SMI,
superior mesenteric artery; IMA, inferior mesenteric artery; Ki, kidney; Ad, adrenal; UB, urinary bladder. 
Figure 2. A: Anatomical templates of lymph node dissection (LND) according to laterality and location of the primary tumor based on a
critical analysis of the current literature: LND templates for tumors of the renal pelvis and upper third of the ureter. RP, renal pelvis; UU,
upper third of the ureter; MU, middle third of the ureter; LU, lower third of the ureter; LN, lymph node. 
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Figure 2. B: Anatomical templates of lymph node dissection (LND) according to laterality and location of the primary tumor based on a critical
analysis of the current literature: LND templates for tumors of the middle third of the ureter.  RP, renal pelvis; UU, upper third of the ureter; MU,
middle third of the ureter; LU, lower third of the ureter; LN, lymph node. C: Anatomical templates of lymph node dissection (LND) according
to laterality and location of the primary tumor based on a critical analysis of the current literature: LND templates for tumors of the lower third
of the ureter. RP, renal pelvis; UU, upper third of the ureter; MU, middle third of the ureter; LU, lower third of the ureter; LN, lymph node.
